248 related articles for article (PubMed ID: 10150254)
21. Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness.
Dietrich W; Thuermel K; Heyde S; Busley R; Berger K
J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):589-96. PubMed ID: 16202891
[TBL] [Abstract][Full Text] [Related]
22. The development of an optimized autologous blood donation program.
Rock G; Bormanis J; Neurath D
Transfus Apher Sci; 2005 Nov; 33(3):325-31. PubMed ID: 16242382
[TBL] [Abstract][Full Text] [Related]
23. Preoperative autologous blood donation in primary total knee arthroplasty: a single-centre experience on 214 consecutive patients.
Franchini M; Regis D; Gandini G; Corallo F; de Gironcoli M; Aprili G
Vox Sang; 2006 Apr; 90(3):191-4. PubMed ID: 16507019
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of unmodified whole blood vs. buffy coat-depleted red cell concentrates in autologous transfusion of elective orthopaedic surgery patients.
Karger R; Stangenberg K; Hinrichs F; Griss P; Kretschmer V
Transfus Med; 2004 Oct; 14(5):347-57. PubMed ID: 15500454
[TBL] [Abstract][Full Text] [Related]
25. [Safety and efficacy of autologous blood donation before elective off-pump coronary artery bypass grafting].
Yoda M; Nonoyama M; Shimakura T
Kyobu Geka; 2004 May; 57(5):367-9. PubMed ID: 15151034
[TBL] [Abstract][Full Text] [Related]
26. Recombinant human erythropoietin for autologous blood donation: effects on perioperative red-blood-cell and serum erythropoietin production.
Tasaki T; Ohto H; Hashimoto C; Abe R; Saitoh A; Kikuchi S
Lancet; 1992 Mar; 339(8796):773-5. PubMed ID: 1347803
[TBL] [Abstract][Full Text] [Related]
27. The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel.
Katz E; Gaitini L; Samri M; Egoz N; Fergusson D; Laupacis A
Isr Med Assoc J; 2001 Nov; 3(11):809-12. PubMed ID: 11729574
[TBL] [Abstract][Full Text] [Related]
28. Autologous blood transfusion in oral and maxillofacial surgery patients with the use of erythropoietin.
Christopoulou M; Derartinian H; Hatzidimitriou G; Iatrou L
J Craniomaxillofac Surg; 2001 Apr; 29(2):118-25. PubMed ID: 11465435
[TBL] [Abstract][Full Text] [Related]
29. The safety of recombinant human erythropoietin therapy in autologous blood donors.
Goodnough LT
J Lab Clin Med; 1994 Jul; 124(1):17-8. PubMed ID: 8035097
[No Abstract] [Full Text] [Related]
30. Minimizing perioperative homologous blood exposure with recombinant human erythropoietin.
Levine EA; Gould SA
Surg Annu; 1993; 25 Pt 1():83-99. PubMed ID: 8416148
[TBL] [Abstract][Full Text] [Related]
31. [Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery].
Bisbe E; Sáez M; Nomen N; Castillo J; Santiveri X; Mestre C; Cano X
Rev Esp Anestesiol Reanim; 2003 Oct; 50(8):395-400. PubMed ID: 14601367
[TBL] [Abstract][Full Text] [Related]
32. [Erythrocytapheresis a few weeks before surgery: an alternative to erythropoietin treatment in programmed autologous transfusion].
Bernière J; Gerota I
Cah Anesthesiol; 1996; 44(4):303-8. PubMed ID: 9033827
[TBL] [Abstract][Full Text] [Related]
33. Successful use of subcutaneous recombinant human erythropoietin before cholecystectomy in an anemic patient with religious objections to transfusion therapy.
Fletcher JL; Perez JC; Jones DH
Am Surg; 1991 Nov; 57(11):697-700. PubMed ID: 1746777
[TBL] [Abstract][Full Text] [Related]
34. Acute treatment with recombinant erythropoietin in patients with pre- and postoperative anemia: a clinical report.
von Bormann B; Weiler J; Aulich S
Clin Investig; 1994; 72(6 Suppl):S31-5. PubMed ID: 7950170
[No Abstract] [Full Text] [Related]
35. Orthopaedic-induced anemia: the fallacy of autologous donation programs.
Cushner FD; Hawes T; Kessler D; Hill K; Scuderi GR
Clin Orthop Relat Res; 2005 Feb; (431):145-9. PubMed ID: 15685068
[TBL] [Abstract][Full Text] [Related]
36. Autologous blood predonation in cardiac surgery.
Dietrich W
Transfus Clin Biol; 2007 Dec; 14(6):526-9. PubMed ID: 18424148
[TBL] [Abstract][Full Text] [Related]
37. [Autologous blood donation].
Kretschmer V
Klin Wochenschr; 1988; 66 Suppl 15():23-8. PubMed ID: 3054283
[TBL] [Abstract][Full Text] [Related]
38. [Erythropoietin treatment: concept and controversy].
Sans Mateu T
Sangre (Barc); 1998 Aug; 43(4):327-30. PubMed ID: 9790000
[No Abstract] [Full Text] [Related]
39. Autologous transfusion and other approaches to reduce allogeneic blood exposure.
Vamvakas EC; Pineda AA
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):533-47. PubMed ID: 11102275
[TBL] [Abstract][Full Text] [Related]
40. Minimizing donor exposure in hemotherapy.
AuBuchon JP
Arch Pathol Lab Med; 1994 Apr; 118(4):380-91. PubMed ID: 8166588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
